Subsequent studies with a mouse model of multiple myeloma [50] and mouse thoracic tumors [51] confirmed the earlier findings that S100A8 and A9 drive MDSC differentiation and function and are associated with aggressive tumor progression. Here, IGKV1D-22 is linked to neoplasm.